• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE TAG THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE TAG THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number TGT3115
Medical Device Problem Code Incomplete or Inadequate Connection (4037)
Health Effect - Clinical Codes Aneurysm (1708); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 08/03/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).A review of the manufacturing records indicated the lot met all pre-release manufacturing specifications.It should be noted the gore® tag® thoracic endoprosthesis instructions for use states ¿complications associated with the use of the gore® tag® thoracic endoprosthesis may include, but are not limited to, endoleak and aneurysm expansion.¿.
 
Event or Problem Description
On (b)(6) 2013, a patient underwent surgical repair of a thoracic aortic aneurysm with arch replacement and an elephant trunk procedure, and then endovascular treatment from the elephant trunk to the descending aorta using two gore® tag® thoracic endoprostheses.A 31mm gore® tag® device was implanted proximally, and a 34mm gore® tag® device was implanted distally.On unknown date, a follow-up computed tomography scan reportedly revealed aneurysm enlargement (amount not reported), and a suspected type ia or type ii endoleak at the proximal send of the aneurysm.On (b)(6) 2021, a reintervention was performed.An angiograph prior to the procedure reportedly showed no significant endoleak.However, the physician suspected a slight proximal type i endoleak from between the elephant trunk and the proximal gore® tag® device due to a gap or insufficient overlap length.An additional 31mm gore® tag® device was implanted to extend to the proximal side.A final procedural angiograph revealed no endoleak.The patient tolerated the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE TAG THORACIC ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key12334045
Report Number2017233-2021-02277
Device Sequence Number2806441
Product Code MIH
UDI-Device Identifier00733132613625
UDI-Public00733132613625
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P040043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2013
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 08/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/31/2016
Device Model NumberTGT3115
Device Catalogue NumberTGT3115
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/03/2021
Initial Report FDA Received Date08/17/2021
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age79 YR
-
-